STROBE-based methodology for detection of adverse events across multiple communities.
Partners Healthcare is one of five institutions in conjunction with eHealth Initiative (eHI) and the FDA that is collaborating in a nation-wide effort to develop novel health information technology tools to create an active drug safety surveillance system across the U.S. The STROBE statement serves as the standard for the definition of a structured, systematic, reproducible approach for detecting both the risks and benefits of drug treatments in multiple settings.
Sordo
Margarita
M
Massachusetts General Hospital, Partners Healthcare, Boston, MA, USA.
Colecchi
Judith
J
Dubey
Anil
A
Dubey
Anil Kumar
AK
Gainer
Vivian
V
Murphy
Shawn N
SN
D016907:Adverse Drug Reaction Reporting Systems / Q000458:organization & administration*; D019058:Community Networks / Q000458:organization & administration*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000145:classification*; D006801:Humans; D033181:Information Dissemination / Q000379:methods*; D008404:Massachusetts; D017410:Practice Guidelines as Topic; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors